Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Depressive Disorder Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Tricyclic Antidepressants
1.2.3 Selective Serotonin Reuptake Inhibitors
1.2.4 Serotonin-Norepinephrine Reuptake Inhibitors
1.2.5 Monoamine Oxidase Inhibitors
1.2.6 Serotonin Antagonist And Reuptake Inhibitors
1.2.7 Others
1.3 Market by Application
1.3.1 Global Depressive Disorder Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.3.5 Homecare Settings
1.3.6 Long Term Care Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Depressive Disorder Market Perspective (2018-2033)
2.2 Depressive Disorder Growth Trends by Region
2.2.1 Global Depressive Disorder Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Depressive Disorder Historic Market Size by Region (2018-2023)
2.2.3 Depressive Disorder Forecasted Market Size by Region (2024-2033)
2.3 Depressive Disorder Market Dynamics
2.3.1 Depressive Disorder Industry Trends
2.3.2 Depressive Disorder Market Drivers
2.3.3 Depressive Disorder Market Challenges
2.3.4 Depressive Disorder Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Depressive Disorder Players by Revenue
3.1.1 Global Top Depressive Disorder Players by Revenue (2018-2023)
3.1.2 Global Depressive Disorder Revenue Market Share by Players (2018-2023)
3.2 Global Depressive Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Depressive Disorder Revenue
3.4 Global Depressive Disorder Market Concentration Ratio
3.4.1 Global Depressive Disorder Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Depressive Disorder Revenue in 2022
3.5 Depressive Disorder Key Players Head office and Area Served
3.6 Key Players Depressive Disorder Product Solution and Service
3.7 Date of Enter into Depressive Disorder Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Depressive Disorder Breakdown Data by Type
4.1 Global Depressive Disorder Historic Market Size by Type (2018-2023)
4.2 Global Depressive Disorder Forecasted Market Size by Type (2024-2033)
5 Depressive Disorder Breakdown Data by Application
5.1 Global Depressive Disorder Historic Market Size by Application (2018-2023)
5.2 Global Depressive Disorder Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Depressive Disorder Market Size (2018-2033)
6.2 North America Depressive Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Depressive Disorder Market Size by Country (2018-2023)
6.4 North America Depressive Disorder Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Depressive Disorder Market Size (2018-2033)
7.2 Europe Depressive Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Depressive Disorder Market Size by Country (2018-2023)
7.4 Europe Depressive Disorder Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Depressive Disorder Market Size (2018-2033)
8.2 Asia-Pacific Depressive Disorder Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Depressive Disorder Market Size by Region (2018-2023)
8.4 Asia-Pacific Depressive Disorder Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Depressive Disorder Market Size (2018-2033)
9.2 Latin America Depressive Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Depressive Disorder Market Size by Country (2018-2023)
9.4 Latin America Depressive Disorder Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Depressive Disorder Market Size (2018-2033)
10.2 Middle East & Africa Depressive Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Depressive Disorder Market Size by Country (2018-2023)
10.4 Middle East & Africa Depressive Disorder Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alkermes
11.1.1 Alkermes Company Detail
11.1.2 Alkermes Business Overview
11.1.3 Alkermes Depressive Disorder Introduction
11.1.4 Alkermes Revenue in Depressive Disorder Business (2018-2023)
11.1.5 Alkermes Recent Development
11.2 Allergan
11.2.1 Allergan Company Detail
11.2.2 Allergan Business Overview
11.2.3 Allergan Depressive Disorder Introduction
11.2.4 Allergan Revenue in Depressive Disorder Business (2018-2023)
11.2.5 Allergan Recent Development
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Company Detail
11.3.2 Bristol Myers Squibb Business Overview
11.3.3 Bristol Myers Squibb Depressive Disorder Introduction
11.3.4 Bristol Myers Squibb Revenue in Depressive Disorder Business (2018-2023)
11.3.5 Bristol Myers Squibb Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Detail
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Depressive Disorder Introduction
11.4.4 Eli Lilly Revenue in Depressive Disorder Business (2018-2023)
11.4.5 Eli Lilly Recent Development
11.5 Glaxosmithkline
11.5.1 Glaxosmithkline Company Detail
11.5.2 Glaxosmithkline Business Overview
11.5.3 Glaxosmithkline Depressive Disorder Introduction
11.5.4 Glaxosmithkline Revenue in Depressive Disorder Business (2018-2023)
11.5.5 Glaxosmithkline Recent Development
11.6 H. Lundbeck
11.6.1 H. Lundbeck Company Detail
11.6.2 H. Lundbeck Business Overview
11.6.3 H. Lundbeck Depressive Disorder Introduction
11.6.4 H. Lundbeck Revenue in Depressive Disorder Business (2018-2023)
11.6.5 H. Lundbeck Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Depressive Disorder Introduction
11.7.4 Merck Revenue in Depressive Disorder Business (2018-2023)
11.7.5 Merck Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Depressive Disorder Introduction
11.8.4 Pfizer Revenue in Depressive Disorder Business (2018-2023)
11.8.5 Pfizer Recent Development
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Company Detail
11.9.2 Teva Pharmaceutical Business Overview
11.9.3 Teva Pharmaceutical Depressive Disorder Introduction
11.9.4 Teva Pharmaceutical Revenue in Depressive Disorder Business (2018-2023)
11.9.5 Teva Pharmaceutical Recent Development
11.10 Takeda Pharmaceutical
11.10.1 Takeda Pharmaceutical Company Detail
11.10.2 Takeda Pharmaceutical Business Overview
11.10.3 Takeda Pharmaceutical Depressive Disorder Introduction
11.10.4 Takeda Pharmaceutical Revenue in Depressive Disorder Business (2018-2023)
11.10.5 Takeda Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Depressive Disorder Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Tricyclic Antidepressants
Table 3. Key Players of Selective Serotonin Reuptake Inhibitors
Table 4. Key Players of Serotonin-Norepinephrine Reuptake Inhibitors
Table 5. Key Players of Monoamine Oxidase Inhibitors
Table 6. Key Players of Serotonin Antagonist And Reuptake Inhibitors
Table 7. Key Players of Others
Table 8. Global Depressive Disorder Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Depressive Disorder Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global Depressive Disorder Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Depressive Disorder Market Share by Region (2018-2023)
Table 12. Global Depressive Disorder Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 13. Global Depressive Disorder Market Share by Region (2024-2033)
Table 14. Depressive Disorder Market Trends
Table 15. Depressive Disorder Market Drivers
Table 16. Depressive Disorder Market Challenges
Table 17. Depressive Disorder Market Restraints
Table 18. Global Depressive Disorder Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Depressive Disorder Market Share by Players (2018-2023)
Table 20. Global Top Depressive Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Depressive Disorder as of 2022)
Table 21. Ranking of Global Top Depressive Disorder Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Depressive Disorder Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Depressive Disorder Product Solution and Service
Table 25. Date of Enter into Depressive Disorder Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Depressive Disorder Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Depressive Disorder Revenue Market Share by Type (2018-2023)
Table 29. Global Depressive Disorder Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 30. Global Depressive Disorder Revenue Market Share by Type (2024-2033)
Table 31. Global Depressive Disorder Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Depressive Disorder Revenue Market Share by Application (2018-2023)
Table 33. Global Depressive Disorder Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 34. Global Depressive Disorder Revenue Market Share by Application (2024-2033)
Table 35. North America Depressive Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Depressive Disorder Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Depressive Disorder Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Depressive Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. Europe Depressive Disorder Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Depressive Disorder Market Size by Country (2024-2033) & (US$ Million)
Table 41. Asia-Pacific Depressive Disorder Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 42. Asia-Pacific Depressive Disorder Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Depressive Disorder Market Size by Region (2024-2033) & (US$ Million)
Table 44. Latin America Depressive Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Latin America Depressive Disorder Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Depressive Disorder Market Size by Country (2024-2033) & (US$ Million)
Table 47. Middle East & Africa Depressive Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 48. Middle East & Africa Depressive Disorder Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Depressive Disorder Market Size by Country (2024-2033) & (US$ Million)
Table 50. Alkermes Company Detail
Table 51. Alkermes Business Overview
Table 52. Alkermes Depressive Disorder Product
Table 53. Alkermes Revenue in Depressive Disorder Business (2018-2023) & (US$ Million)
Table 54. Alkermes Recent Development
Table 55. Allergan Company Detail
Table 56. Allergan Business Overview
Table 57. Allergan Depressive Disorder Product
Table 58. Allergan Revenue in Depressive Disorder Business (2018-2023) & (US$ Million)
Table 59. Allergan Recent Development
Table 60. Bristol Myers Squibb Company Detail
Table 61. Bristol Myers Squibb Business Overview
Table 62. Bristol Myers Squibb Depressive Disorder Product
Table 63. Bristol Myers Squibb Revenue in Depressive Disorder Business (2018-2023) & (US$ Million)
Table 64. Bristol Myers Squibb Recent Development
Table 65. Eli Lilly Company Detail
Table 66. Eli Lilly Business Overview
Table 67. Eli Lilly Depressive Disorder Product
Table 68. Eli Lilly Revenue in Depressive Disorder Business (2018-2023) & (US$ Million)
Table 69. Eli Lilly Recent Development
Table 70. Glaxosmithkline Company Detail
Table 71. Glaxosmithkline Business Overview
Table 72. Glaxosmithkline Depressive Disorder Product
Table 73. Glaxosmithkline Revenue in Depressive Disorder Business (2018-2023) & (US$ Million)
Table 74. Glaxosmithkline Recent Development
Table 75. H. Lundbeck Company Detail
Table 76. H. Lundbeck Business Overview
Table 77. H. Lundbeck Depressive Disorder Product
Table 78. H. Lundbeck Revenue in Depressive Disorder Business (2018-2023) & (US$ Million)
Table 79. H. Lundbeck Recent Development
Table 80. Merck Company Detail
Table 81. Merck Business Overview
Table 82. Merck Depressive Disorder Product
Table 83. Merck Revenue in Depressive Disorder Business (2018-2023) & (US$ Million)
Table 84. Merck Recent Development
Table 85. Pfizer Company Detail
Table 86. Pfizer Business Overview
Table 87. Pfizer Depressive Disorder Product
Table 88. Pfizer Revenue in Depressive Disorder Business (2018-2023) & (US$ Million)
Table 89. Pfizer Recent Development
Table 90. Teva Pharmaceutical Company Detail
Table 91. Teva Pharmaceutical Business Overview
Table 92. Teva Pharmaceutical Depressive Disorder Product
Table 93. Teva Pharmaceutical Revenue in Depressive Disorder Business (2018-2023) & (US$ Million)
Table 94. Teva Pharmaceutical Recent Development
Table 95. Takeda Pharmaceutical Company Detail
Table 96. Takeda Pharmaceutical Business Overview
Table 97. Takeda Pharmaceutical Depressive Disorder Product
Table 98. Takeda Pharmaceutical Revenue in Depressive Disorder Business (2018-2023) & (US$ Million)
Table 99. Takeda Pharmaceutical Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Depressive Disorder Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Depressive Disorder Market Share by Type: 2022 VS 2033
Figure 3. Tricyclic Antidepressants Features
Figure 4. Selective Serotonin Reuptake Inhibitors Features
Figure 5. Serotonin-Norepinephrine Reuptake Inhibitors Features
Figure 6. Monoamine Oxidase Inhibitors Features
Figure 7. Serotonin Antagonist And Reuptake Inhibitors Features
Figure 8. Others Features
Figure 9. Global Depressive Disorder Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 10. Global Depressive Disorder Market Share by Application: 2022 VS 2033
Figure 11. Hospitals Case Studies
Figure 12. Ambulatory Surgical Centers Case Studies
Figure 13. Diagnostic Centers Case Studies
Figure 14. Homecare Settings Case Studies
Figure 15. Long Term Care Centers Case Studies
Figure 16. Depressive Disorder Report Years Considered
Figure 17. Global Depressive Disorder Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 18. Global Depressive Disorder Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 19. Global Depressive Disorder Market Share by Region: 2022 VS 2033
Figure 20. Global Depressive Disorder Market Share by Players in 2022
Figure 21. Global Top Depressive Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Depressive Disorder as of 2022)
Figure 22. The Top 10 and 5 Players Market Share by Depressive Disorder Revenue in 2022
Figure 23. North America Depressive Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. North America Depressive Disorder Market Share by Country (2018-2033)
Figure 25. United States Depressive Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Canada Depressive Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Depressive Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Europe Depressive Disorder Market Share by Country (2018-2033)
Figure 29. Germany Depressive Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Depressive Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Depressive Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Depressive Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Depressive Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Depressive Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific Depressive Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Asia-Pacific Depressive Disorder Market Share by Region (2018-2033)
Figure 37. China Depressive Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Japan Depressive Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. South Korea Depressive Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Southeast Asia Depressive Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. India Depressive Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Australia Depressive Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America Depressive Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Latin America Depressive Disorder Market Share by Country (2018-2033)
Figure 45. Mexico Depressive Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Brazil Depressive Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa Depressive Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East & Africa Depressive Disorder Market Share by Country (2018-2033)
Figure 49. Turkey Depressive Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Saudi Arabia Depressive Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Alkermes Revenue Growth Rate in Depressive Disorder Business (2018-2023)
Figure 52. Allergan Revenue Growth Rate in Depressive Disorder Business (2018-2023)
Figure 53. Bristol Myers Squibb Revenue Growth Rate in Depressive Disorder Business (2018-2023)
Figure 54. Eli Lilly Revenue Growth Rate in Depressive Disorder Business (2018-2023)
Figure 55. Glaxosmithkline Revenue Growth Rate in Depressive Disorder Business (2018-2023)
Figure 56. H. Lundbeck Revenue Growth Rate in Depressive Disorder Business (2018-2023)
Figure 57. Merck Revenue Growth Rate in Depressive Disorder Business (2018-2023)
Figure 58. Pfizer Revenue Growth Rate in Depressive Disorder Business (2018-2023)
Figure 59. Teva Pharmaceutical Revenue Growth Rate in Depressive Disorder Business (2018-2023)
Figure 60. Takeda Pharmaceutical Revenue Growth Rate in Depressive Disorder Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed